Edit
Aliada Therapeutics
https://www.aliadatx.com/Last activity: 29.10.2024
Probably Closed - Reference to AbbVie
Aliada is developing a platform to improve drug delivery to the brain for multiple modalities including, monoclonal antibodies, enzymes, and oligonucleotides
Investors 1
| Date | Name | Website |
| 30.08.2023 | OrbiMed | orbimed.co... |
Mentions in press and media 3
| Date | Title | Description |
| 29.10.2024 | AbbVie’s Bold Move: Acquiring Aliada Therapeutics for CNS Breakthroughs | In a strategic maneuver that echoes the age-old adage, "the early bird catches the worm," AbbVie has set its sights on the burgeoning field of central nervous system (CNS) therapeutics. The Chicago-based pharmaceutical giant annou... |
| 28.10.2024 | AbbVie to Acquire Aliada Therapeutics | AbbVie (NYSE: ABBV), Chicago, IL-based acquired Aliada Therapeutics, a Boston, MA-based biotechnology company focused on central nervous system (CNS) diseases. AbbVie will acquire all outstanding Aliada equity for $1.4 Billion in cash, subj... |
| - | Aliada Therapeutics | “Aliada Therapeutics” |